The Role of Prescription Drug Coverage in Benefits

Prescription Drug Plan Design: A Risk You Don't Manage

July 28, 2026

Prescription drug coverage is the line item that looks like a benefit but functions like a financial risk lever. Most employers treat it as a fixed cost to minimize at renewal. The result is a pharmacy benefit designed around premium savings, not around how employees actually use medications. That gap has a price. It shows up in emergency room visits, hospitalizations, and short-term disability claims that dwarf whatever was saved on the monthly premium. The coverage decision and the cost consequence rarely land in the same budget line, so the connection goes unmanaged.

In This Post

How Drug Coverage Works and Why the Design Decisions Are Financial Ones
What Are the Key Design Features of Effective Drug Coverage?
The Benefits of Prescription Insurance Depend on Who Needs Drug Coverage and How the Plan Is Built Around Them
Why the Usual Fix Doesn't Work and What Actually Does
Strategic Approaches for Employers to Manage Prescription Drug Plans
What Watching Employers Underinvest in Drug Coverage Teaches You
How TBG Helps Employers Manage Prescription Drug Costs

Key Takeaways

Nonadherence is an employer cost problem, not an employee behavior problem	When employees ration medications because of high out-of-pocket costs, the bill lands in your inpatient and ER claims, not in their copay totals. The plan design created the behavior.
Formulary structure determines whether employees actually take their medications	Tiering, deductible exemptions, and prior authorization rules shape medication adherence more than any wellness program. A well-designed formulary is a clinical tool.
Discount cards feel like savings and aren't	GoodRx and similar cards bypass insurance entirely. Purchases made through them do not count toward deductibles or out-of-pocket maximums, which means employees on high-deductible plans can spend all year filling prescriptions and never satisfy their deductible.
Front-loading specialty fills early in the year produces real savings	Filling high-cost prescriptions in January accelerates progress toward the out-of-pocket maximum. Once that cap is hit, every subsequent fill is free. For specialty drug users, this can mean thousands of dollars saved annually.
The employers who consistently spend less on pharmacy look at claims data between renewals	Renewal-only reviews catch the problem after it has already cost you. Quarterly claims review lets you see medication rationing signals, like low refill rates on maintenance drugs, before they become hospitalizations.

How Drug Coverage Works and Why the Design Decisions Are Financial Ones

Your pharmacy benefit is not a soft benefit. It is the part of the plan that determines which medications employees can access, at what cost, and under what conditions. Those decisions shape medication adherence, chronic disease management, and total claims spending. Get them wrong and the savings you thought you captured at renewal show up as something more expensive by October.

Cost-related medication rationing affects roughly 10% of Medicaid-enrolled adults and 8% of privately insured adults, compared to 17% of the uninsured. That gap is not a population effect. It is a coverage design effect. The plan you build is what creates the behavior.

The Medicare evidence is instructive. After the Inflation Reduction Act took effect, cost-related nonadherence dropped 4.9 percentage points overall among Medicare beneficiaries. For people managing two or more chronic conditions, the drop was 7.8 percentage points. That is not marginal. It is a structural shift driven entirely by removing financial barriers to medication access. The same logic applies to your plan.

Restrictive formularies and high copays push employees to skip doses or abandon therapy. That raises total medical costs for your chronic disease population. The numbers are not theoretical:

Employees with uncontrolled diabetes generate higher inpatient claims than those with consistent medication access.
Asthma patients who ration inhalers because of cost are more likely to use urgent care and emergency services.
Specialty drug users who hit cost walls mid-year often abandon therapy entirely, which accelerates disease progression and long-term plan costs.

When you pull your pharmacy data, look specifically at 30-day refill rates for maintenance medications. Low refill rates on diabetes, hypertension, or asthma drugs are an early warning that cost barriers are building toward something much more expensive. By the time it shows up as a hospital claim, the window to intervene has already passed.

What Are the Key Design Features of Effective Drug Coverage?

The formulary is the single most consequential design decision in a prescription drug plan. It is the plan's approved drug list, organized into tiers that determine cost-sharing at each level. Tier 1 covers generic drugs at the lowest copay, typically $10 to $20 per fill. Tier 2 covers preferred brand drugs. Tier 3 and above cover non-preferred brands and specialty medications at the highest cost-sharing levels.

Many plans exempt Tier 1 generic drugs from deductibles entirely, applying a flat copay from the first fill. That one design choice reduces cost burden immediately and encourages generic substitution, which lowers plan spending without reducing clinical quality. It costs less than you think and changes employee behavior faster than almost anything else you can do at renewal.

Deductible structure matters as much as the formulary itself. In 2026, Medicare Part D sets its deductible cap at $615 and its out-of-pocket maximum at $2,100, with the catastrophic phase costing beneficiaries nothing. Employer plans vary widely, but the principle holds: the higher the deductible, the more employees pay before coverage activates, and the more likely they are to ration medications in January and February, which is the worst possible time.

Generic deductible	Applied	Exempt, flat copay
Brand drug copay	$50 to $80	$30 to $50
Out-of-pocket max	$5,000+	$2,000 to $3,500
Prior authorization	Broad use	Limited to specialty
90-day supply option	Not available	Available, lower cost
Home delivery	Not offered	Offered, discounted

Prior authorization, the process where the plan requires clinical review before covering a drug, adds administrative friction that delays care. Applied broadly, beyond specialty drugs, it creates barriers that disproportionately affect employees with complex conditions. Appeals and exception processes exist, but they require employee initiative that most people simply will not take without direct guidance. You get the friction either way.

Push your carrier or pharmacy benefit manager to limit prior authorization to Tier 3 and specialty drugs only. Broad prior authorization on Tier 2 drugs generates administrative cost and frustrated employees without producing meaningful savings. That is a bad trade at any premium level.

The Benefits of Prescription Insurance Depend on Who Needs Drug Coverage and How the Plan Is Built Around Them

The low-premium, high-copay plan is the most common cost-shifting move in employer benefits. It reduces your monthly contribution, which looks great on the renewal sheet, and transfers financial risk directly to employees. For healthy employees with minimal medication needs, that tradeoff is manageable. For employees managing hypertension, Type 2 diabetes, or rheumatoid arthritis, it is a direct path to skipped doses and larger claims later in the year.

Narrow formularies create a different problem. Employees whose medications are not on the formulary face two choices: pay full price out of network, or switch medications. Neither is clean. Switching requires physician involvement, prior authorization, and sometimes a clinical adjustment period. Full-price purchases outside the plan do not count toward deductibles or out-of-pocket maximums.

Third-party discount cards like GoodRx are worth understanding here. Employees use them, often without realizing that those purchases bypass insurance entirely and provide no progress toward their annual deductible or out-of-pocket limit. An employee on a $1,500 drug deductible who fills every prescription through a discount card will end the year having never satisfied that deductible and never accessed the plan's cost-sharing benefits. They thought they were being smart about costs. The plan design let them down.

Broad formulary plans improve employee satisfaction and reduce mid-year plan abandonment.
High-deductible plans paired with health savings accounts work well for healthy, low-utilization employees but create real hardship for chronic condition populations.
Pharmacy costs depend on plan tiers, not pharmacy shelf prices. Employees who do not understand this consistently overpay.
The value of prescription coverage scales with how much someone needs it. High-need families benefit far more from plans with lower access barriers than employees who fill one prescription a year.

Why the Usual Fix Doesn't Work and What Actually Does

Most employer conversations about pharmacy spend get framed as a premium problem, so the solution becomes a premium solution: raise deductibles, narrow the formulary, shift copays. That approach controls what is visible at renewal and defers what is expensive into the claim year. By Q3, the math has reversed.

The real driver is the gap between what your plan is designed to cover and what your workforce actually needs. A pharmacy benefit built for a healthy, low-utilization population will fail a workforce with a meaningful share of employees managing chronic conditions. That mismatch does not show up on the renewal sheet. It shows up in inpatient claims, ER utilization, and turnover among the employees who depend on the benefit most.

The employers who consistently spend less on pharmacy over time are not the ones with the lowest premiums. They are the ones who look at utilization data between renewals and adjust plan design to match their actual workforce, not a carrier's actuarial average. That distinction matters more than almost any lever available at the renewal table.

Affordable medication access is a financial discipline. The plan that keeps an employee's blood pressure controlled all year costs less than the plan that sends them to the ER in October. That is not an abstraction. It is a straightforward comparison of two line items.

Strategic Approaches for Employers to Manage Prescription Drug Plans

Benefits leaders who treat pharmacy plan design as a once-a-year renewal exercise miss most of the available savings. The decisions that move numbers happen between renewals: employee education, formulary navigation support, and data review. Here is where to start.

Audit your claims data by drug tier. Identify which Tier 3 and specialty drugs are driving the most spend. Then determine whether a therapeutically equivalent option exists on Tier 1 or Tier 2. A single specialty drug switch can reduce annual plan costs by tens of thousands of dollars.
Educate employees on formulary navigation. Employees can contact their physicians to request a formulary-covered alternative or submit a coverage exception request. Most do not know this option exists. A one-page guide at open enrollment can change that, for essentially no cost.
Encourage front-loading for high-cost drug users. Filling expensive prescriptions early in the plan year accelerates progress toward the out-of-pocket maximum. Once an employee reaches that cap, every subsequent fill is cost-free. For specialty drug users, this strategy can save thousands annually.
Offer 90-day supply and home delivery options. These reduce per-unit drug costs and improve refill consistency. Consistent refills mean better adherence. Better adherence means fewer acute events. It is a short chain with a real outcome at the end.
Work with a pharmacy benefit consultant. Plan design decisions made without claims-level data consistently leave money on the table. A consulting partner with access to cost-saving benefits strategies can identify formulary gaps, pharmacy benefit manager contract inefficiencies, and employee education opportunities that internal HR teams rarely have bandwidth to pursue.

If your workforce includes a meaningful share of employees managing chronic conditions, model the financial impact of lowering Tier 2 copays by $10. The reduction in ER and inpatient claims from improved adherence often exceeds the premium cost of the change. Run the numbers before you assume you cannot afford it.

What Watching Employers Underinvest in Drug Coverage Teaches You

Most employers I work with did not set out to design a bad pharmacy benefit. They set out to control costs, reached for the most visible lever, and ended up with a plan that looked cheaper at renewal and cost more by Q3. That is not bad intent. It is a predictable outcome of optimizing for the wrong number.

The pattern I see most often in nonprofits and care-based organizations is a workforce with a meaningful share of employees managing chronic conditions, paired with a pharmacy benefit built for a healthy, low-utilization population. The mismatch is expensive. It produces medication rationing, avoidable hospitalizations, and turnover among the employees who need benefits most, which, in a care-based organization, is a particular kind of irony.

The fix is not always spending more. Sometimes it is spending differently. Exempting generics from the deductible costs very little and changes employee behavior immediately. Communicating the out-of-pocket maximum strategy to specialty drug users costs nothing and can save those employees thousands. Understanding employee cost sharing at the plan design level, not just the premium level, is where real savings live.

The employers who get this right treat pharmacy benefits as a clinical and financial tool at the same time. They review claims data quarterly, communicate formulary changes proactively, and partner with consultants who can translate pharmacy benefit manager contract language into actual cost implications. That discipline is not complicated. It just requires looking at the data, which most organizations have and most do not use.

Jacob

Work With a Benefits Advisor Who Understands Your Sector

Thrive Benefits Group works with employers across the Southeast, particularly nonprofits and care-based organizations, to build pharmacy benefit structures that reduce costs without reducing access, starting with your claims data. Schedule a conversation to talk through your specific situation.

Schedule a Consultation

How TBG Helps Employers Manage Prescription Drug Costs

TBG's consulting approach identifies formulary inefficiencies, pharmacy benefit manager contract gaps, and employee education opportunities that most HR teams do not have time to find on their own. The Thrivebg Cornerstone platform gives employers a centralized view of their benefits performance, including pharmacy spend, so decisions are grounded in actual utilization data rather than carrier estimates. If your current drug benefit is costing more than it should, the starting point is a conversation about what your claims data actually shows.

Frequently Asked Questions

What is the role of prescription drug coverage in employee benefits?

Prescription drug coverage determines which medications employees can access, at what cost, and under what conditions. It directly influences medication adherence, chronic disease management, and total healthcare spending for the plan. Plan design decisions, including formulary structure and cost-sharing levels, have measurable effects on downstream medical claims.

How does formulary design affect employee medication adherence?

Plans with restrictive formularies and high copays cause employees to skip or ration medications, which raises downstream medical costs through increased emergency and inpatient utilization. Exempting generic drugs from deductibles and limiting prior authorization requirements to specialty drugs are the two design changes that most reliably improve adherence.

Do third-party discount cards count toward my deductible?

No. Purchases made through discount cards like GoodRx bypass insurance entirely and do not count toward annual deductibles or out-of-pocket maximums. Employees on high-deductible plans who use discount cards for every fill may spend the entire year paying out of pocket without ever satisfying their deductible or accessing the plan's cost-sharing benefits.

What is the best strategy for employees with high-cost specialty drugs?

Filling specialty drug prescriptions early in the plan year accelerates progress toward the out-of-pocket maximum. Once that cap is reached, all subsequent fills for the remainder of the year are cost-free. For employees on expensive specialty medications, front-loading fills in January or February can produce thousands of dollars in annual savings.

How can HR professionals reduce prescription drug costs without cutting coverage?

Auditing claims data by drug tier, encouraging generic substitution, educating employees on formulary navigation and coverage exception requests, and offering 90-day supply options are the highest-impact steps available without reducing benefit levels. Each addresses a different point of leakage: unnecessary brand drug spend, patient abandonment, and poor refill consistency.